Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brodalumab in RA with Inadequate Response to Methotrexate
NCT00950989Phase 2Completed
- Sponsor
- Amgen
- Start
- Dec 2009
- Primary completion
- Feb 2011
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of brodalumab in rheumatoid arthritis (RA), sponsored by Amgen. Started Dec 2009; status: completed.
02
Drugs
brodalumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00950989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00950989.